INS and type 1 diabetes mellitus: A 34‐year woman with long‐lasting T1D, a recent history of weight gain in the range of mild overweight (BMI 26.9 kg/m2), and glucose control deterioration (HbA1c 8.3%) was intensified with Semaglutide up to 1 mg/week in add‐on to background basal‐bolus treatment and reported marked weight loss (−12 kg) and significant amelioration of body composition (drop in fat mass by 15% and visceral fat mass by 7%) along with reduction of insulin requirement, and amelioration of glucose control [72].